Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

1-Acylglycerol-3-Phosphate O-Acyltransferase 2 (Lysophosphatidic Acid Acyltransferase, Beta) (AGPAT2) (C-Term) Peptide

AGPAT2 Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN8093567
$145.08
Plus shipping costs $50.00
100 μg
Shipping to: United States
Delivery in 2 to 4 Business Days

Quick Overview for 1-Acylglycerol-3-Phosphate O-Acyltransferase 2 (Lysophosphatidic Acid Acyltransferase, Beta) (AGPAT2) (C-Term) Peptide (ABIN8093567)

Target

AGPAT2 (1-Acylglycerol-3-Phosphate O-Acyltransferase 2 (Lysophosphatidic Acid Acyltransferase, Beta) (AGPAT2))

Origin

Human

Source

  • 5
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    C-Term

    Purpose

    AGPAT2 Peptide - C-terminal region

    Sequence

    QVPIVPVVYS SFSSFYNTKK KFFTSGTVTV QVLEAIPTSG LTAADVPALV
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Comment

    This is a synthetic peptide designed for use in combination with anti-AGPAT2 Antibody (ARP44636_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Buffer

    Lyophilized powder

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
  • Target

    AGPAT2 (1-Acylglycerol-3-Phosphate O-Acyltransferase 2 (Lysophosphatidic Acid Acyltransferase, Beta) (AGPAT2))

    Background

    Background Information: AGPAT2 is a member of the 1-acylglycerol-3-phosphate O-acyltransferase family. The protein is located within the endoplasmic reticulum membrane and converts lysophosphatidic acid to phosphatidic acid, the second step in de novo phospholipid biosynthesis. Mutations in its gene have been associated with congenital generalized lipodystrophy (CGL), or Berardinelli-Seip syndrome, a disease characterized by a near absence of adipose tissue and severe insulin resistance.

    Alternative Symbols: 1-AGPAT2, BSCL, BSCL1, LPAAB, LPAAT-beta

    Molecular Weight

    31kDa

    Gene ID

    10555

    NCBI Accession

    NP_006403

    UniProt

    O15120
You are here:
Chat with us!